[Epilepsy: epidemiology and social aspects].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 11523423)

Published in Vestn Ross Akad Med Nauk on January 01, 2001

Authors

A B Gekht, E I Gusev, I V Kurkina, O B Lokshina, A V Lebedeva, L E Mil'chakova

Articles by these authors

[Blood-brain barrier]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.96

Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology (2002) 0.91

Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. J Clin Pharm Ther (2006) 0.90

Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol Lett (2001) 0.89

The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology (2002) 0.88

[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.88

[Epidemiological characteristics of multiple sclerosis in Russia]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.85

Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Mosc) (1998) 0.85

Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav (2009) 0.85

[Polymorphic variants of genes encoding interleukin-6 and fibrinogen, the risk of ischemic stroke and fibrinogen levels]. Mol Biol (Mosk) (2012) 0.81

[Cerebrovascular disorders in patients with coronary bypass surgery]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.80

[Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians]. Mol Biol (Mosk) (2002) 0.80

Dialectics and implications of natural neurotropic autoantibodies in neurological disease and rehabilitation. Clin Dev Immunol (2004) 0.79

[Neurological disturbances in heroin addicts in acute withdrawal and early post-abstinence periods]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.79

[Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene]. Mol Biol (Mosk) (1998) 0.78

[Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Zh Nevrol Psikhiatr Im S S Korsakova (1997) 0.78

[Adherence to long-term therapy with disease modifying drugs]. Zh Nevrol Psikhiatr Im S S Korsakova (2009) 0.78

[The clinico-neurophysiological study of the effect of cerebrolysin on brain function in the acute and early recovery periods of hemispheric ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.78

[Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy]. Mol Biol (Mosk) (2012) 0.78

[Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.78

[Endogenous intoxication and compensatory reactions in the restoration period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2010) 0.78

Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians. Neurology (2003) 0.78

[Clinico-neurological and stabilometric analysis of betahistine (betaserc) efficacy in the patients with vertigo in the rehabilitation period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.77

[Clinical significance of humoral compensatory reactions in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.77

Levels of neurotransmitter amino acids in the cerebrospinal fluid of patients with acute ischemic insult. Neurosci Behav Physiol (2001) 0.77

[Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency]. Zh Nevrol Psikhiatr Im S S Korsakova (2005) 0.77

[Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials]. Zh Nevrol Psikhiatr Im S S Korsakova (2010) 0.77

[Treatment of vestibular vertigo and Ménière syndrome in outpatient clinics]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.77

[Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study)]. Zh Nevrol Psikhiatr Im S S Korsakova (2006) 0.77

Acquisition of an active avoidance reaction in rats and morphological changes in the hippocampus in pentylenetetrazol kindling. Neurosci Behav Physiol (2010) 0.77

[Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease]. Urologiia (2006) 0.77

[The level of autoantibodies to glutamate receptors in the blood serum of patients in the acute period of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1996) 0.77

[The circadian changes of plasma and blood viscosity and hematocrit in patients with ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (2008) 0.76

Impaired production of plasma interleukin-6 in patients with Parkinson's disease. Bull Exp Biol Med (2002) 0.76

[Cerebral stroke: problems and solutions]. Vestn Ross Akad Med Nauk (2003) 0.76

[Association between DNA antibodies levels in the blood of patients with multiple sclerosis and clinical presentation of the disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2003) 0.76

Change in platelet monoamine oxidase activity in the acutest period of ischemic stroke is associated with the degree of neurological recovery. Bull Exp Biol Med (2011) 0.75

[Neuropsychological deficit in chronic heroin abusers]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75

[The risk factors for the development of multiple sclerosis in the Moscow population. II. The combination of exogenous and hereditary factors]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75

[Catecholamine metabolism in different forms of Parkinson's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75

[Risk factors of multiple sclerosis in Moscow population. I. Exogenous risk factors]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75

[Differential diagnostic criteria of lateral amyotrophic sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2002) 0.75

[The effect of different hyperbaric oxygenation regimens on the aggregate status of the blood and on the free-radical oxidation processes in patients with the initial manifestations of cerebral blood supply failure]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.75

[Plasma and erythrocyte free amino acid concentration in patients in the acute period of an ischemic stroke]. Zh Nevropatol Psikhiatr Im S S Korsakova (1981) 0.75

[Status of central and cerebral hemodynamics in patients with occlusive lesions of major arteries of the head in the acute period of ischemic stroke]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75

[The basic factors affecting outcomes in strokes]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75

[The use of NMR tomography for the dynamic observation of patients with disseminated sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (1993) 0.75

[A clinico-biochemical study of patients with hereditary diseases of the nervous system with a mental retardation syndrome]. Zh Nevropatol Psikhiatr Im S S Korsakova (1969) 0.75

[Ultrastructural aspects of acute cerebral ischemia during nootropil administration (experimental study)]. Zh Nevropatol Psikhiatr Im S S Korsakova (1983) 0.75

[Clinico-neurophysiological studies of the conductive affective and effective systems of the brain in the acute period of ischemic stroke]. Zh Nevropatol Psikhiatr Im S S Korsakova (1992) 0.75

[The possibility of the use of several clinical, genetic and MRI characteristics for the prognosis of effects of beta-interferon-1beta treatment in multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75

[Disseminated intravascular coagulation in acute cerebral circulatory disorders]. Zh Nevropatol Psikhiatr Im S S Korsakova (1985) 0.75

[A comprehensive clinico-neurophysiological study of the efficacy of the pharmaceutical preparation glycine in acute ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75

[Ultrastructural aspects of acute cerebral ischemia after treatment with barbiturates]. Zh Nevropatol Psikhiatr Im S S Korsakova (1982) 0.75

[Modern approaches to beta-interferon application in therapy of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75

[Ischemic brain disease]. Vestn Ross Akad Med Nauk (1994) 0.75

[Features of neurotransmitter pool in cerebrospinal fluid of patients with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova (2001) 0.75

[Mechanisms of the therapeutic effect of hyperbaric oxygenation in minor differential pressure in stroke]. Zh Nevropatol Psikhiatr Im S S Korsakova (1990) 0.75

[The complex clinico-electrophysiological assessment of the motor disorders in patients in the early period of recovery from an ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1993) 0.75

[Results of clinico-immunological testing of myelopid in chronic forms of multiple sclerosis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1992) 0.75

[The cerebral and central hemodynamics of patients with vertebrobasilar stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1994) 0.75

[Meeting of the committee of the World Federation of Neurologists on education: graduate education in neurology]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75

[Incidence and the degree of compensation of diseases of the nervous system]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75

[Computer-assisted spectrum analysis of Doppler ultrasonograms in occlusive lesions of the carotid arteries]. Zh Nevropatol Psikhiatr Im S S Korsakova (1990) 0.75

[Control and assessment of the quality of professional competence among physicians and students]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75

[Clinico-electrophysiologic, immunologic and biochemical studies of multiple sclerosis patients]. Zh Nevropatol Psikhiatr Im S S Korsakova (1983) 0.75

[Results of neurologic examination of patients with occlusive lesions of the major arteries of the brain in the long-term postoperative period]. Zh Nevropatol Psikhiatr Im S S Korsakova (1985) 0.75

[Spectrum of neuropsychological changes in multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75

[Emergency medical services for acute cerebral circulatory disorders]. Zh Nevropatol Psikhiatr Im S S Korsakova (1977) 0.75

Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol (2000) 0.75

[Clinical and immunochemical characteristics of remittent multiple sclerosis]. Vestn Ross Akad Med Nauk (1999) 0.75

[Osmotic homeostasis and blood rheology in patients in the acute period of ischemic cerebral infarction]. Zh Nevropatol Psikhiatr Im S S Korsakova (1990) 0.75

[A clinico-neurophysiological analysis and the treatment problems of the crush syndrome (based on data from the earthquake in Armenia)]. Zh Nevropatol Psikhiatr Im S S Korsakova (1991) 0.75

[Genetic polymorphism of a human gene locus containing the tumor necrosis factor gene: new markers of susceptibility to multiple sclerosis]. Dokl Akad Nauk (1995) 0.75

[Ultrastructural aspects of the secondary brain stem syndrome in hemorrhages and infarcts in the cerebral hemispheres]. Zh Nevropatol Psikhiatr Im S S Korsakova (1986) 0.75

[Hyperbaric oxygenation in the treatment of compression mononeuropathies]. Sov Med (1991) 0.75

[Clinico-immunological monitoring of the condition of patients with multiple sclerosis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1992) 0.75

[Mechanisms of brain tissue damage in acute focal ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75

[The current standards for the diagnosis and treatment of epilepsy in Europe]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75

[Comparative clinico-immuno-chemical analysis of remittent and secondary-progressive course of multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2000) 0.75

[Use of polyamine in the complex treatment of multiple sclerosis]. Zh Nevropatol Psikhiatr Im S S Korsakova (1985) 0.75

Compressed spectral analysis of the EEG in patients with acute cerebrovascular disturbance. Neurosci Behav Physiol (1985) 0.75

[Clinico-biochemical and morphologic characteristics of mucopolysaccharidoses]. Vestn Akad Med Nauk SSSR (1976) 0.75

[Diagnosis and treatment and preventive measures in the presence of initial manifestations of insufficient cerebral blood supply]. Zh Nevropatol Psikhiatr Im S S Korsakova (1983) 0.75

[Dynamics of the functional state of the brain in acute focal ischemia]. Patol Fiziol Eksp Ter (1993) 0.75

[Analysis of two segments of biallelic polymorphism at the tumor necrosis factor in patients with multiple sclerosis from the Russian population: connection with NcoI-PDGF in the first intron of the lymphotoxin alpha gene]. Mol Biol (Mosk) (1999) 0.75

[Clinico-immunobiochemical monitoring of factors of focal inflammation in the acute period of hemispheric ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova (1999) 0.75

[Ultrasonic flow metering in the diagnosis of occlusive lesions of the extracranial portions of the carotid arteries]. Zh Nevropatol Psikhiatr Im S S Korsakova (1977) 0.75

[Experience in using T-activin in multiple sclerosis patients]. Zh Nevropatol Psikhiatr Im S S Korsakova (1984) 0.75

[Clinical aspects, diagnosis and treatment of progressive muscular dystrophies]. Med Sestra (1974) 0.75

[A clinico-experimental study of amino acid metabolism in progressive muscular dystrophy]. Zh Nevropatol Psikhiatr Im S S Korsakova (1970) 0.75

[Leukodystrophy in children]. Zh Nevropatol Psikhiatr Im S S Korsakova (1974) 0.75

[Amino acid and nucleic acid contents of muscles in hereditary muscular dystrophies]. Izv Akad Nauk SSSR Biol (1971) 0.75

[Encephaloradiothermometry in the diagnosis of early stages of cerebrovascular insufficiency]. Zh Nevropatol Psikhiatr Im S S Korsakova (1989) 0.75

[The practical clinical game and discussion as active teaching methods in the training of the future physician]. Zh Nevrol Psikhiatr Im S S Korsakova (1995) 0.75